We are live on ! Find out more
RNLX

Renalytix plc American Depositary Shares

Delisted

RNLX was delisted on the 7th of October, 2024.

41 hedge funds and large institutions have $180M invested in Renalytix plc American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 6

50% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 8

18% more capital invested

Capital invested by funds: $152M → $180M (+$27.4M)

8% more funds holding

Funds holding: 3841 (+3)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

5% less call options, than puts

Call options by funds: $1.77M | Put options by funds: $1.87M

Holders
41
Holders Change
+3
Holders Change %
+7.89%
% of All Funds
0.71%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
9
Increased
12
Reduced
8
Closed
6
Calls
$1.77M
Puts
$1.87M
Net Calls
-$100K
Net Calls Change
-$2.36M
Name Holding Trade Value Shares
Change
Change in
Stake
GGHC
1
Gilder Gagnon Howe & Co
New York
$101M +$7.36M +245,701 +8%
FAM
2
Fred Alger Management
New York
$16.2M +$5.63M +188,017 +56%
PGM
3
Parian Global Management
New York
$15.9M -$9.57M -319,673 -38%
ACH
4
ArrowMark Colorado Holdings
Colorado
$11.9M -$496K -16,577 -4%
Fidelity International
5
Fidelity International
Bermuda
$8.58M
GG
6
Gofen & Glossberg
Illinois
$4.77M
PA
7
Pinnacle Associates
New York
$3.7M +$656K +21,904 +22%
PCM
8
Pentwater Capital Management
Florida
$3.09M -$524K -17,500 -15%
SC
9
Scholtz & Company
Connecticut
$2.71M +$87.7K +2,930 +3%
Lazard Asset Management
10
Lazard Asset Management
New York
$1.79M +$1.71M +57,119 +6,354%
SCM
11
Soleus Capital Management
Connecticut
$1.46M -$979K -32,700 -41%
MHP
12
Manatuck Hill Partners
Connecticut
$1.33M
SGM
13
Skye Global Management
Florida
$1.2M +$509K +17,000 +77%
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
$807K +$783K +26,159 New
PC
15
Plaisance Capital
Colorado
$710K +$689K +23,000 New
Citadel Advisors
16
Citadel Advisors
Florida
$618K +$599K +20,009 New
PPA
17
Parametric Portfolio Associates
Washington
$557K +$15.2K +509 +3%
Bank of America
18
Bank of America
North Carolina
$414K
Jane Street
19
Jane Street
New York
$378K +$367K +12,265 New
ASN
20
Advisory Services Network
Georgia
$368K +$59.8K +1,996 +20%
HA
21
Harbor Advisors
Florida
$309K
RC
22
RBF Capital
California
$309K
Renaissance Technologies
23
Renaissance Technologies
New York
$253K +$245K +8,200 New
Millennium Management
24
Millennium Management
New York
$249K -$1.63M -54,441 -87%
M&T Bank
25
M&T Bank
New York
$223K +$216K +7,227 New

RNLX Hedge Fund Activity: Q2 2021 in Review

41 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Renalytix plc American Depositary Shares (RNLX) for Q2 2021, worth a combined $180M — up 18% from $152M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new RNLX positions and 6 closed out — a net gain of 3 holders — while 12 added to existing stakes and 8 trimmed.

The largest buyer was Gilder Gagnon Howe & Co, adding an estimated $7.36M. The largest seller was Parian Global Management, cutting an estimated $9.57M.

  • 41 institutional investors held Renalytix plc American Depositary Shares (RNLX) as of Q2 2021, up from 38 in Q1 2021.
  • Funds reported $180M of Renalytix plc American Depositary Shares stock for Q2 2021, up 18% quarter-over-quarter.
  • 9 funds opened new Renalytix plc American Depositary Shares positions in Q2 2021 and 6 closed out, a net change of +3 holders.
  • The largest Renalytix plc American Depositary Shares buyer in Q2 2021 was Gilder Gagnon Howe & Co, an estimated $7.36M added.
  • The largest Renalytix plc American Depositary Shares seller in Q2 2021 was Parian Global Management, an estimated $9.57M sold.

Based on aggregated 13F filings for Q2 2021.